• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 大流行期间实验室环境、门诊、医疗中心和兽医医院的一般生物安全措施。

General biosafety measures for laboratory environments, outpatient clinics, medical centers, and veterinary hospitals during the SARS-CoV-2 pandemic.

机构信息

Programa de Pós-Graduação em Medicina Veterinária (PPGMV), Departamento de Medicina Veterinária Preventiva (DMVP), Centro de Ciências Rurais (CCR), Universidade Federal de Santa Maria (UFSM), Prédio 44, Sala 5125/5132, Santa Maria, Rio Grande do Sul (RS), CEP 97105-900, Brazil.

Departamento de Microbiologia e Parasitologia, Instituto de Biologia (IB), Universidade Federal de Pelotas (UFPel), Travessa André Dreyfus, s/nº. Campus Universitário Capão do Leão. Prédios 18 e 25, Capão do Leão, RS, CEP 96010-900, Brazil.

出版信息

Braz J Microbiol. 2022 Sep;53(3):1715-1721. doi: 10.1007/s42770-022-00734-0. Epub 2022 Mar 29.

DOI:10.1007/s42770-022-00734-0
PMID:35352318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8962927/
Abstract

This study aimed to guide professionals working in veterinary laboratories, outpatient clinics, medical centers, and hospitals regarding the biosafety measures that should be adopted during the novel coronavirus (SARS-CoV-2) pandemic. While the population is not yet fully immunized by vaccines, the adoption of biosafety measures is essential to control the spread of circulating strains of the new coronavirus. Thus, the importance of professionals and collaborators following biosafety guidelines in different veterinary work environments is highlighted. The main protocols on biosafety to be adopted include frequent handwashing with water and soap or using 70% alcohol-based hand sanitizers, using personal protective equipment (PPE) (including gloves, lab coat, face mask), avoiding the contact of the hands with mucous membranes (eyes, nose and mouth), not sharing personal objects, keeping environments clean and well ventilated, social distancing of 1.5 m between individuals, and maintaining objects and surfaces regularly clean throughout the work environment. The transformation of work processes, such as various biosafety practices, is necessary within the context of the COVID-19 pandemic and improves the safety of professionals in their work environment and other people and animals, decreasing contamination risks in order to reduce the spread of this viral agent.

摘要

本研究旨在为兽医实验室、门诊诊所、医疗中心和医院的专业人员提供指导,介绍在新型冠状病毒(SARS-CoV-2)大流行期间应采取的生物安全措施。虽然人群尚未完全通过疫苗实现免疫,但采取生物安全措施对于控制新型冠状病毒循环株的传播至关重要。因此,强调了专业人员和合作者在不同兽医工作环境中遵循生物安全指南的重要性。应采用的主要生物安全协议包括经常用肥皂和水洗手或使用含 70%酒精的手部消毒剂、使用个人防护设备(包括手套、实验服、口罩)、避免手部接触粘膜(眼睛、鼻子和嘴巴)、不共享个人物品、保持环境清洁和通风良好、个人之间保持 1.5 米的社交距离,并定期清洁整个工作环境中的物品和表面。在 COVID-19 大流行背景下,需要改变工作流程,例如采取各种生物安全措施,从而提高工作环境中专业人员以及其他人和动物的安全性,降低污染风险,以减少这种病毒传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d5/9433481/65a3804a5052/42770_2022_734_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d5/9433481/65a3804a5052/42770_2022_734_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d5/9433481/65a3804a5052/42770_2022_734_Fig1_HTML.jpg

相似文献

1
General biosafety measures for laboratory environments, outpatient clinics, medical centers, and veterinary hospitals during the SARS-CoV-2 pandemic.SARS-CoV-2 大流行期间实验室环境、门诊、医疗中心和兽医医院的一般生物安全措施。
Braz J Microbiol. 2022 Sep;53(3):1715-1721. doi: 10.1007/s42770-022-00734-0. Epub 2022 Mar 29.
2
A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic.新型冠状病毒肺炎疫情期间采供血机构实验室生物安全防护措施调查。
Vox Sang. 2021 Jul;116(6):682-691. doi: 10.1111/vox.13051. Epub 2021 Feb 2.
3
Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey.应对 COVID-19 爆发期间生物危害风险的实验室实践:IFCC 全球调查。
Clin Chem Lab Med. 2020 Jun 4;58(9):1433-1440. doi: 10.1515/cclm-2020-0711. Print 2020 Aug 27.
4
Biosafety during a pandemic: shared resource laboratories rise to the challenge.大流行期间的生物安全:共享资源实验室迎接挑战。
Cytometry A. 2021 Jan;99(1):68-80. doi: 10.1002/cyto.a.24280. Epub 2021 Jan 4.
5
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.临床实验室预防 COVID-19 感染的生物安全措施:IFCC 工作组建议。
Clin Chem Lab Med. 2020 Jun 25;58(7):1053-1062. doi: 10.1515/cclm-2020-0633.
6
Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.孟加拉国建立 COVID-19 生物安全检测实验室面临的挑战。
J Infect Dev Ctries. 2021 Dec 31;15(12):1833-1837. doi: 10.3855/jidc.14415.
7
Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.生物安全原则在新型冠状病毒肺炎患者临床样本实验室检测中的应用
J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S48-S51. doi: 10.5455/JPMA.10.
8
Meta-analysis to explain unknown causes of the origins of SARS-COV-2.针对 SARS-CoV-2 起源的未知原因进行的荟萃分析。
Environ Res. 2022 Aug;211:113062. doi: 10.1016/j.envres.2022.113062. Epub 2022 Mar 5.
9
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.《COVID-19 疫情期间生物化学实验室的运行考虑因素和挑战:IFCC 全球调查》。
Clin Chem Lab Med. 2020 Jun 4;58(9):1441-1449. doi: 10.1515/cclm-2020-0710. Print 2020 Aug 27.
10
Biosafety Concerns During the Collection, Transportation, and Processing of COVID-19 Samples for Diagnosis.生物安全关切在新冠病毒样本的收集、运输和处理过程中用于诊断。
Arch Med Res. 2020 Oct;51(7):623-630. doi: 10.1016/j.arcmed.2020.08.007. Epub 2020 Sep 12.

本文引用的文献

1
SARS-CoV-2 transmission without symptoms.新型冠状病毒2(SARS-CoV-2)无症状传播。
Science. 2021 Mar 19;371(6535):1206-1207. doi: 10.1126/science.abf9569.
2
Hospital biosecurity capacitation: Analysis and recommendations for the prevention and control of COVID-19.医院生物安全能力建设:新冠疫情防控的分析与建议
J Biosaf Biosecur. 2020 Mar;2(1):5-9. doi: 10.1016/j.jobb.2020.05.001. Epub 2020 May 27.
3
Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review.限制/遏制和应对严重急性呼吸综合征冠状病毒2/冠状病毒病疫情的生物安全和生物安保措施:快速综述
Turk J Biol. 2020 Jun 21;44(3):132-145. doi: 10.3906/biy-2005-63. eCollection 2020.
4
Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks.常见医用口罩滤布材料的气溶胶过滤效率。
ACS Nano. 2020 May 26;14(5):6339-6347. doi: 10.1021/acsnano.0c03252. Epub 2020 Apr 24.
5
Enhancing the National Biosecurity System in China amidst COVID-19 Epidemic.在新冠疫情期间加强中国国家生物安全体系
J Biosaf Biosecur. 2020 Mar;2(1):3-4. doi: 10.1016/j.jobb.2020.03.002. Epub 2020 Apr 17.
6
Can companion animals become infected with Covid-19?伴侣动物会感染新冠病毒吗?
Vet Rec. 2020 Apr 4;186(13):419-420. doi: 10.1136/vr.m1322.
7
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.冠状病毒在无生命表面上的持久性及其用杀生物剂灭活。
J Hosp Infect. 2020 Mar;104(3):246-251. doi: 10.1016/j.jhin.2020.01.022. Epub 2020 Feb 6.
8
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析优先报告条目:PRISMA声明
PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.